Overview
Working with HPAPIs requires a deep understanding of the complexities and liabilities involved. Investment to ensure employees and their environment are protected from exposure is a must.
In this first sesision of our new HPAPI webinar series, our product stewardship toxicologists, Dr. Daniel Bertow and Dr. Andrea Marburger, start you off on the journey of assessing the risks of new and marketed chemical entity APIs and the associated intermediates. Drawing on years of experience, our speakers provide you with an understanding of the workflow, evaluation process, software and studies typically utilized, as well as key information needed to make a formal assessment of safe handling procedures.
This webinar is suitable for anyone working in procurement, outsourcing, EHS, quality assurance, or as a project manager, who is interested in understanding the whole assessment process and their role in it.
Key learnings for participants of this webinar:- Overview of established methodology and benchmarking within the pharma industry
- Understanding data requirements for sustainable and high-quality safety assessments
Related webinars in this series
This is the first webinar of our 3-part webinar series entitled "Handling HPAPIs: From toxicological risk assessment to metric ton manufacturing". Join us to follow the journey of a highly potent molecule, starting from toxicological assessment to initial tech transfer and development onto large scale (metric ton) commercial manufacture.
To learn more about the two other webinars in this series please click on the respective webinar below. To register for multiple webinars of this series simply select them in the registration form.
